Clinical useful of coccidioidin skin test in subjects with type 2 diabetes mellitus in an endemic area;Utilidad de la prueba cutánea a la coccidioidina en personas con diabetes mellitus tipo 2 en una zona endémica

Revista de Investigacion Clinica

Volumn 53, Issue 3, 2001, Pages 223-227

  Velasco Rodríguez, Víctor M ^a,c   Martinez Ordaz, Verónica A ^a   Padua Y Gabriel, Antonio ^a   Lazo Sáenz, Juan G ^a   Cicero Sabido, Raúl ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNAM ^*  (Mexico)

Author keywords

Coccidioidin; Diabetes mellitus; Prevalence; Skin reactivity

Indexed keywords

COCCIDIOIDIN; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; COCCIDIOIDOMYCOSIS; CROSS-SECTIONAL STUDY; ENDEMIC DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; MEXICO; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; SKIN TEST; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHILD; COCCIDIOIDIN; COCCIDIOIDOMYCOSIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENDEMIC DISEASES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEXICO; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN TESTS;

EID: 0345778109     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. González Ochoa A. Epidemiología de la coccidiodomicosis en México. Gac Med Mex 1967; 97:1383.
2. Stevens DA. Coccidioidomycosis. New Engl J Med 1995; 332: 1077-82.
3. Kirckland TN, Fierer J. Coccidioidomycosis. A reemerging infectious disease. Emerg Infect Dis 1996; 2: 192-9.
4. Hedges E, Miller S. Coccidioidomycosis: Office diagnosis and treatment. AFP 1990; 41: 1495-506.
5. Schneider E, Hajjeh RA, Siegel RA, Jibson RW, Harp EL, Marshall GA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 1997; 277: 904-8.
6. Singh VR, Smith OK, Lawrence J. Coccidioidomycosis in patients infected with human immunodeficiency virus: Review of 91 cases at a single institution. Clin Infect Dis 1996; 23: 563-8.
7. Brownnimann DA, Adam RP, Galgiani NJ. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106: 372-9.
8. Galgiani JN, Yam P, Petz LD, Williams PL, Stevens DA. Complement activation by Coccidiodes immitis: In vitro and clinical studies. Infect Immun 1980; 28: 944-9.
9. Galgiani JN. Inhibition of different phases of Coccidioides immitis by human neutrophils on hidrogen peroxide. J Infect Dis 1985; 153: 217-22.
10. Kirkland TN, Zhu SW, Kruse D, Hsu LL, Seshan KR, Cole GT. Coccidioides immitis reactions which are antigenic for immune T lymphocytes. Infect Immun 1991; 59: 3952-61.
11. Becman L, Benjamini E, Pappagianis D. Activation of macrophages by lymphokines: Enhancement of phagosome-lysosome fusion and killing of Coccidioides immitis. Infect immun 1983; 39: 1201-7.
12. Cox RA, Pape RM, Stevens DA. Immunocomplexes in coccidioidomycosis, correlation with disease involvement. Am Rev Resp Dis 1982; 126:439-43.
13. Catanzaro A. Suppresor cells in coccidioidomycosis. Cell Immunol 1981; 64: 235.
14. Catanzaro A, Spitler LE, Moser KM. Cellular immune response in Coccidioidomycosis. Cell Immunol 1975; 15: 360-71.
15. Cunha BA. Infections in nonleukopenic compromised hosts (Diabetes mellitus, SLE, stheroids and asplenia) in critical care. Review. Critical Care Clinics 1998; 14: 263-82.
16. Tsukaguchi H, Okamura H, Ikunu M, Kobuyashi A, Fukouka A, Takenaka H, Yamamoto C, Tukuyama T, Okamoto Y, Fu A, Yoshikawa M, Yoneda T, Nanta N. The relation between diabetes mellitus and IFn-gamma, IL-2 and IL-10 by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis. Kekkaku 1997; 72: 617-22.
17. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among hispanics. Am J Pub Health 1997; 87: 574-9.
18. Maruisi M, Marani G, Brianti M, Della Porta R. Pulmonary complications in diabetes mellitus. Recent Prog Med 1996; 87: 623-7.
19. Morley JE. The elderly type Z diabetic patient. Special considerations. Review. Diabetic medicine 1998; 15 (suppl 4): S41-46.
20. Rees JR, Pinner RW, Hajjeh RA, Brnadt ME, Reingold AL. The epidemological features of invasive mycotic infection in the San Francisco Bay Area, 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis 1998; 27: 1138-47.
21. Campbell SC, Smith JP. An evaluation of reactivity to Coccidioides immitis skin test in subjects with diabetes mellitus. Mycopathologia 1982; 80: 133-6.
22. Leake JA, Mosley DG, England B, Graham JV, Plikaytis BD, Ampel NN, et al. Risk Factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Inf Dis 2000; 181: 1435-40.
23. Westphal SA, Sarosi GA. Diabetic ketoacidosis associated with pulmonary coccidioidomycosis cases. Clin Infect Dis 1994; 18: 974-8.
24. Karachunskii MA, Gergert Vla, Iakovleva DB. Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus. Probl Tuberk 1997; 6: 59-60.
25. Craddock T, Shefta J, Gibey SG, Lancaster FC, Baylston AW. Individuals form multiplex insulin dependent diabetes mellitus families express highers levels of TCRBV2S1 than controls. Hum Immunol 1998; 59: 39-47.
26. Pickup JC, Mattock MB, Chausney GD, Burt D. NIDDM as a disease of the innate immune system: Association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetology 1997; 40: 1286-92.
27. Tschoepe D, Rauch U, Schwippent B. Platelet leukocyte cross talk in diabetes mellitus. Horm Metab Res 1997; 29: 631-5.
28. Sarosi GA, Catanzaro A, Daniel TM, Davies SF. Clinical usefulness of skin testing in histoplasmosis, coccidioidomycosis and blastomycosis. Am Rev Resp Dis 1988; 138: 1081-2.
29. Dodge RR, Lebowitz MD, Barbee R, Burrows B. Estimates of C. immitis by skin test reactivity in an endemic community. Am J Publ Health 1985; 75: 863-5.
30. Carrada-Bravo T. La coccidioidomicosis en los niños. Bol Med Hosp Inf Mex 1989; 46: 507-14.
31. Davies SF, Sarosi GA. Role of serodiagnostic tests and skin tests in the diagnosis of fungal diseases. Clin Chest Med 1987; 81: 135-46.
32. Verduzco E, Portales A, Monjardin S. Características clínicas y epidemiológicas de la coccidioidomicosis en la Comarca Lagunera. Salud Pública Mex 1965; 7: 397.
33. Padua y Gabriel A, Martínez-Ordaz VA, Velasco-Rodríguez VM, Lazo-Saenz JG, Cicero-Sabido R. Prevalence of skin reactivity to coccidioidin and associated risks factors in subjects living in a northern city of Mexico. Arch Med Res 1999; 30: 388-92.
34. Verneuil L, Boisseau-Gerseud AM, Desbois N, Garsaud P, Helenon R, Cales-Quist D. Histoplasmin skin test survey in hospitalized patients in the french west indies (Martinique). Annales de Dermatologie et de venereologie 1999; 126: 405-7.
35. Machin D, Campbell MJ, Fayers PM, Pinol AP. Sample size tables for clinical studies. Blackwell Science 2nd. ed. 1997. UK.
36. The Expert Committee on the diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
37. Oldfield EC 3rd, Bone WD, Martin CR, Gray GC, Olson P, Schillaci RF. Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis 1997; 25: 1205-10.
38. Stromberg LGE, Luduigsson GJ, Bjorkten B. Atopic allergy and delayed-hypersensitivity in children with diabetes. J Allerg Clin Immunol 1995; 96: 188-92